Ivan Šnajdr

8PUBLICATIONS
44CO-AUTHORS
TribologyChemical engineering designPredictive and prognostic markersImmunogenetics (incl. genetic immunology)Biologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 20, 2025
Mechanistic insights into TTLL11 polyglutamylase-mediated primary tubulin chain elongation.

Jana Campbell, Miroslava Vosahlikova, Samar Ismail

|Jan 23, 2025
Discovery of Orally Available Prodrugs of Itaconate and Derivatives.

Chae Bin Lee, Ivan Šnajdr, Lukáš Tenora

|Nov 10, 2023
Discovery of tert-Butyl Ester Based 6-Diazo-5-oxo-l-norleucine Prodrugs for Enhanced Metabolic Stability and Tumor Delivery.

Kateřina Novotná, Lukáš Tenora, Eva Prchalová

|Aug 09, 2023
A gut-restricted glutamate carboxypeptidase II inhibitor reduces monocytic inflammation and improves preclinical colitis.

Diane E Peters, Lauren D Norris, Lukáš Tenora

|Jul 01, 2023
Comprehensive Mechanistic View of the Hydrolysis of Oxadiazole-Based Inhibitors by Histone Deacetylase 6 (HDAC6).

Lucia Motlová, Ivan Šnajdr, Zsófia Kutil

|Mar 11, 2023
Selectivity of Hydroxamate- and Difluoromethyloxadiazole-Based Inhibitors of Histone Deacetylase 6 In Vitro and in Cells.

Jakub Ptacek, Ivan Snajdr, Jiri Schimer

Pageof 2